Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-31

Clinical Trial Update: Tranexamic Acid in Vaginal Reconstructive Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tranexamic acid in vaginal reconstructive surgery for pelvic organ prolapse has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Pelvic Organ Prolapse | Phase 4 | Status: WITHDRAWN